Literature DB >> 3096196

Evidence for multiple forms of type I chromosomal beta-lactamase in Pseudomonas aeruginosa.

M L Gates, C C Sanders, R V Goering, W E Sanders.   

Abstract

The multiple stages of derepression of the type I chromosomal beta-lactamase in Pseudomonas aeruginosa were examined. Mutants partially and fully derepressed for beta-lactamase were selected from a wild-type clinical isolate. An analysis of the beta-lactamase produced by these mutants and the induced wild type revealed significant differences in the products of derepression at each stage. Beta-lactamase produced by the fully derepressed mutant showed a lower affinity (Km, 0.113 mM) for cephalothin than that produced by the partially derepressed mutant (Km, 0.049 mM). However, due to a very large Vmax, the former possessed a much greater hydrolytic efficiency. Differences in substrate profile were also noted. Only beta-lactamase from the fully derepressed mutant hydrolyzed cefamandole, cefoperazone, and cefonicid. The partially derepressed mutant possessed a single beta-lactamase band with a pI of 8.4. The fully derepressed mutant possessed this band and an additional major band with a pI of 7.5. Induction of the wild type with cefoxitin produced both bands. The changes in physiologic parameters of the enzymes produced in the different stages of derepression suggest a complex system for beta-lactamase expression in P. aeruginosa. This may involve at least two distinct structural regions, each of which is under control of the same repressor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096196      PMCID: PMC180579          DOI: 10.1128/AAC.30.3.453

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  SYNERGISTIC ACTION OF PENICILLINS AND CEPHALOSPORINS AGAINST PSEUDOMONAS PYOCYANEA.

Authors:  L D SABATH; E P ABRAHAM
Journal:  Nature       Date:  1964-12-12       Impact factor: 49.962

2.  Mutant of Pseudomonas aeruginosa 18S that synthesizes type Id beta-lactamase constitutively.

Authors:  F Flett; N A Curtis; M H Richmond
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

3.  Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy.

Authors:  M Matthew; A M Harris
Journal:  J Gen Microbiol       Date:  1976-05

4.  Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.

Authors:  T D Gootz; C C Sanders; R V Goering
Journal:  J Infect Dis       Date:  1982-07       Impact factor: 5.226

5.  Purification and properties of cephalosporinase from Pseudomonas aeruginosa.

Authors:  T Murata; S Minami; K Yasuda; S Iyobe; M Inoue; S Mitsuhashi
Journal:  J Antibiot (Tokyo)       Date:  1981-09       Impact factor: 2.649

6.  Isolation and properties of an inducible and a constitutive beta-lactamase from Pseudomonas aeruginosa.

Authors:  M Berks; K Redhead; E P Abraham
Journal:  J Gen Microbiol       Date:  1982-01

7.  Penicillin-binding proteins of Pseudomonas aeruginosa. Comparison of two strains differing in their resistance to beta-lactam antibiotics.

Authors:  N A Curtis; D Orr; M G Boulton; G W Ross
Journal:  J Antimicrob Chemother       Date:  1981-02       Impact factor: 5.790

Review 8.  beta-Lactamases and their clinical significance.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

9.  Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea.

Authors:  L D Sabath; M Jago; E P Abraham
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

10.  [Kinetics of a new cephalosporinase from Pseudomonas aeruginosa].

Authors:  R Labia; C Fabre; M Guionie
Journal:  Biochimie       Date:  1976       Impact factor: 4.079

View more
  12 in total

1.  AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump.

Authors:  Daniel J Wolter; Nancy D Hanson; Philip D Lister
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

2.  Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance.

Authors:  Amber J Schmidtke; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 3.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

4.  Characterization of a Carbapenem-Hydrolyzing Enzyme, PoxB, in Pseudomonas aeruginosa PAO1.

Authors:  Diansy Zincke; Deepak Balasubramanian; Lynn L Silver; Kalai Mathee
Journal:  Antimicrob Agents Chemother       Date:  2015-11-30       Impact factor: 5.191

5.  Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin.

Authors:  P D Lister; V M Gardner; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 6.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 7.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

8.  Heterogeneity of class I beta-lactamase expression in clinical isolates of Pseudomonas aeruginosa.

Authors:  C C Sanders; M L Gates; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

9.  Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins.

Authors:  D L Dworzack; M P Pugsley; C C Sanders; E A Horowitz
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 10.  Beta-lactam antibiotics: from antibiosis to resistance and bacteriology.

Authors:  Kok-Fai Kong; Lisa Schneper; Kalai Mathee
Journal:  APMIS       Date:  2010-01       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.